Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model. (Q49092782)

18 February 2018

title

Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model. (English)

1 reference

18 February 2018

0 references

6

1 reference

18 February 2018

Sho Aoki

object named as

Sho Aoki

3

0 references

author name string

Jun Nojima

1

1 reference

18 February 2018

Azusa Maeda

2

1 reference

18 February 2018

Satoshi Suo

4

1 reference

18 February 2018

Dai Yanagihara

5

1 reference

18 February 2018

Taiji Yoshida

7

1 reference

18 February 2018

Shoichi Ishiura

8

1 reference

18 February 2018

language of work or name

English

0 references

publication date

2 July 2011

1 reference

18 February 2018

published in

Vaccine

1 reference

18 February 2018

volume

29

1 reference

18 February 2018

page(s)

6252-6258

1 reference

18 February 2018

issue

37

1 reference

18 February 2018

Defining molecular targets to prevent Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Alzheimer's disease: the amyloid cascade hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Expression of amyloid-beta 1-40 and 1-42 peptides in Capsicum annum var. angulosum for oral immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Reduction of amyloid beta-peptide accumulation in Tg2576 transgenic mice by oral vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Production of anti-amyloid β antibodies in mice fed rice expressing amyloid β.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Transgenic rice expressing amyloid β-peptide for oral immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

Alterations of behavior and spatial learning after unilateral entorhinal ablation of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.073

10.1016/J.VACCINE.2011.06.073

7 January 2021

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

21726591

1 reference

18 February 2018